Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trialsL. A. Smith, Alison Jones, Mark Verrill et al.|BMC Cancer|2010Cited by 755
Expert opinion on the use of anthracyclines in patients with advanced breast cancer at cardiac riskPeter Barrett‐Lee, Mark Verrill, J. Michael Dixon et al.|Annals of Oncology|2009Cited by 198